08048035968
Global Pharma Supply of INVISTA 500 MG | South Korea Export | Phoenix Exim – Trusted Supplier


1. General Information

INVISTA is a prescription anti-cancer medicine containing Dasatinib, a targeted therapy belonging to the class of medicines known as tyrosine kinase inhibitors (TKIs). Dasatinib is primarily used in the treatment of certain types of blood cancers, particularly Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL).

Dasatinib works by blocking abnormal proteins responsible for signaling cancer-cell growth and multiplication. It is generally prescribed and monitored by an oncologist or hematologist.

Important: Invista listings found in current pharmaceutical sources show strengths such as 50 mg, 70 mg and 100 mg. The stated 500 mg strength should be verified with the product packaging/manufacturer before listing or supplying.

2. Product Information

  • Brand Name: Invista

  • Active Ingredient: Dasatinib

  • Drug Class: Tyrosine Kinase Inhibitor

  • Therapeutic Category: Anti-Cancer / Oncology Medicine

  • Dosage Form: Tablet

  • Commonly Listed Strengths: 50 mg, 70 mg and 100 mg

  • Manufacturer commonly associated with Invista: Dr. Reddy's Laboratories

  • Prescription Status: Prescription medicine

  • Primary Treatment Area: Certain blood cancers, including CML and Ph+ ALL

3. Uses of INVISTA

Dasatinib may be prescribed for:

  • Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)

  • Certain cases of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)

  • Newly diagnosed Ph+ CML in the chronic phase

  • CML or ALL when previous treatment has not provided an adequate response or is not tolerated

The exact indication and treatment regimen depend on the patient's diagnosis, age, previous treatment and clinical condition.

4. Benefits of INVISTA

When prescribed appropriately, dasatinib can provide the following therapeutic benefits:

  • Helps control abnormal growth of leukemia cells

  • Targets specific cancer-driving tyrosine kinase proteins

  • Can be used in certain Ph+ leukemia treatment protocols

  • Provides a targeted treatment approach rather than acting as a conventional nonspecific chemotherapy medicine

  • May be useful when some other leukemia treatments are ineffective or poorly tolerated

Treatment response varies between patients and should be evaluated through regular medical follow-up and laboratory testing.

5. Side Effects of INVISTA

Like other anti-cancer medicines, dasatinib can cause side effects. Some may be mild, while others require immediate medical attention.

Possible side effects include:

  • Low blood cell counts

  • Anemia

  • Reduced platelet count

  • Reduced white blood cell count

  • Headache

  • Nausea

  • Diarrhea

  • Vomiting

  • Skin rash

  • Fatigue

  • Muscle or joint pain

  • Fluid retention

Dasatinib can also cause serious complications such as bleeding, severe reduction in blood-cell counts, fluid around the lungs, heart-related problems and other significant reactions. Patients should remain under appropriate medical supervision.

6. Common Side Effects

Some commonly reported effects may include:

  • Headache

  • Nausea

  • Diarrhea

  • Vomiting

  • Tiredness

  • Muscle or joint discomfort

  • Skin rash

  • Abdominal discomfort

  • Changes in blood-cell counts

Contact a healthcare professional if side effects become persistent, severe or unusual.

7. How to Use INVISTA

Take INVISTA exactly according to the dosage and schedule prescribed by your doctor.

General administration guidance includes:

  • Take the tablet at approximately the same time each day.

  • Swallow the tablet whole with water.

  • Do not crush, chew or break the tablet unless specifically instructed by a healthcare professional.

  • It may generally be taken with or without food according to the prescribed instructions.

  • Do not change the dose or stop treatment without consulting your doctor.

  • If a dose is missed, follow your healthcare professional's instructions rather than taking an additional dose on your own.

Because dasatinib is a potent prescription oncology medicine, the dosage should be individualized by the treating specialist.

8. How INVISTA Works

INVISTA contains dasatinib, which works by inhibiting specific tyrosine kinases involved in the growth and survival of abnormal leukemia cells.

In Ph+ leukemia, abnormal BCR-ABL signaling plays an important role in uncontrolled cancer-cell growth. Dasatinib blocks BCR-ABL and other relevant kinase activity, thereby interfering with signals that encourage leukemia cells to multiply.

This targeted mechanism helps control the abnormal cells responsible for the disease.

9. Safety Advice for INVISTA

  • Use only under the supervision of a qualified oncologist or hematologist.

  • Regular blood tests may be required to monitor blood-cell counts.

  • Inform your doctor about all medicines, supplements and herbal products you take.

  • Tell your doctor if you have a history of heart problems, bleeding disorders, liver problems or lung problems.

  • Avoid grapefruit and grapefruit juice unless your healthcare professional specifically advises otherwise, as they may increase dasatinib exposure.

  • Seek urgent medical attention for unusual bleeding, severe breathing difficulty, chest pain, fainting or signs of serious infection.

  • Do not discontinue cancer treatment suddenly without medical advice.

  • Pregnant or breastfeeding patients should discuss treatment with their doctor before using dasatinib.

  • Keep the medicine out of the reach of children.

  • Store according to the manufacturer's instructions.

10. FAQ's

Q1. What is INVISTA used for?

INVISTA contains dasatinib and is used to treat certain Philadelphia chromosome-positive blood cancers, including CML and Ph+ ALL.

Q2. What is the active ingredient in INVISTA?

The active ingredient is Dasatinib.

Q3. Is INVISTA a chemotherapy medicine?

Dasatinib is an anti-cancer medicine, but it is specifically classified as a targeted tyrosine kinase inhibitor rather than traditional nonspecific chemotherapy.

Q4. Can INVISTA be taken without a prescription?

No. Dasatinib is a prescription oncology medicine and should be used only under appropriate medical supervision.

Q5. What are the common side effects?

Headache, nausea, diarrhea, vomiting, fatigue, rash and changes in blood-cell counts can occur.

Q6. Can I stop INVISTA when I feel better?

No. Do not stop dasatinib without discussing it with your treating doctor.

Q7. Does INVISTA require regular blood tests?

Yes. Doctors commonly monitor blood counts and other relevant parameters during treatment.

Q8. Can INVISTA interact with other medicines?

Yes. Dasatinib can interact with several medicines, so inform your doctor about all prescription, OTC and herbal products you use.

Q9. Is INVISTA 500 mg available?

The pharmaceutical sources reviewed list Invista primarily in 50 mg, 70 mg and 100 mg strengths. Therefore, the claimed 500 mg strength should be verified against the original product packaging and manufacturer information before publication.

Q10. Who should prescribe INVISTA?

Treatment should be determined by an oncologist or another appropriately qualified healthcare professional experienced in managing leukemia.

11. Substitute for INVISTA

Potential substitutes for dasatinib should contain the same active ingredient, strength and appropriate dosage form, but the exact substitute depends on the patient's prescription and treatment plan.

Examples of dasatinib products may include:

  • Generic Dasatinib Tablets

  • Dasatinib tablets from other approved manufacturers

  • Other branded dasatinib products

Do not replace INVISTA with another anti-cancer medicine without approval from the treating oncologist. Different leukemia medicines are not automatically interchangeable.

12. SEO Keywords

  1. Invista 500 mg tablets supplier from India

  2. Invista tablets exporter from India

  3. Dasatinib tablets supplier India

  4. Dasatinib medicine exporter

  5. Invista Dasatinib tablets India

  6. Anti cancer medicine exporter India

  7. Leukemia medicine supplier from India

  8. CML treatment medicine supplier

  9. Dasatinib tablets wholesale supplier

  10. Invista medicine export from India

  11. Dasatinib pharmaceutical exporter

  12. Generic Dasatinib tablets supplier

  13. Invista tablets global supplier

  14. Blood cancer medicine exporter India

  15. Ph+ leukemia medicine supplier

  16. Dasatinib CML medicine exporter

  17. Oncology medicine supplier India

  18. Prescription cancer medicine exporter

  19. Invista medicine supplier USA

  20. Invista medicine supplier UK

  21. Invista medicine supplier Australia

  22. Invista medicine supplier Canada

  23. Invista medicine supplier Singapore

  24. Invista medicine supplier South Korea

  25. Invista medicine supplier UAE

  26. Dasatinib exporter to USA

  27. Dasatinib exporter to UK

  28. Dasatinib exporter to Australia

  29. Dasatinib exporter to Canada

  30. Dasatinib exporter to Singapore

  31. Dasatinib exporter to South Korea

  32. Dasatinib exporter to UAE

  33. Indian pharmaceutical medicine exporter

  34. Phoenix Exim oncology medicine supplier

  35. Phoenix Exim global pharmaceutical exporter

Sep 11th, 2026 2:01 PM

Keywords